Skip to main content
. 2018 Aug 10;8:306. doi: 10.3389/fonc.2018.00306

Table 1.

Somatic mutations identified in the primary tumor, metastasis and plasma.

Gene Chr: position Ref allele Mut allele Codon change Protein change Variant type VAF%
Tumor Metastasis PS1
KRAS chr12: 25398284 C A c.35G>T p.Gly12Val Missense 43.28 35.86 23.23
TP53 chr17: 7578406 C T c.524G>A p.Arg175His Missense 80.23 61.35 28.27
RB1 chr13: 49033902 T C c.2039T>C p.Ile680Thr Missense 11.11 1.08 ND
ALK chr2: 29443666 C T c.3551G>A p.Gly1184Glu Missense 25.89 ND ND
ERBB2 chr17: 37881388 A G c.2580A>G p.Lys860Lys Synonymous 19.66 ND ND

Chr, chromosome; Ref, reference allele; Mut, mutated allele; VAF, variant allele frequency; PS1, plasma sample #1 (pretreatment) ND, not detected.

HHS Vulnerability Disclosure